Blood Collection Devices Market - Global Forecast To 2030
商品番号 : SMB-10957
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 270 |
| 図表数 | 394 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
採血装置市場 – 製品（チューブ（血漿（EDTA、ヘパリン）、血清）、注射針とシリンジ、血液バッグ、モニター）、方法（手動、自動）、用途（診断、治療）、エンドユーザー（病院、血液銀行） – 2030年までの世界予測
世界の採血装置市場は、2025年の91億3,000万米ドルから2030年には130億2,000万米ドルに達し、予測期間中に7.4%の年平均成長率（CAGR）で成長すると予測されています。採血装置市場を牽引する主な要因はいくつかあります。感染症の蔓延、慢性疾患、生活習慣病の増加に伴い、頻繁かつ信頼性の高い血液検査の必要性が高まっています。同時に、世界中で病院や手術センターの数が増加し、医療インフラが拡充され、効率的な採血ソリューションに対する需要が高まっています。また、事故や外傷の増加により、救急医療や輸血のための迅速かつ安全な採血の必要性がさらに高まっています。さらに、がんの早期発見とモニタリングのために血液サンプルを使用するリキッドバイオプシー検査の登場により、サンプルの品質と精度を確保する高度な採血装置の需要が高まっています。献血や血液成分に対する意識の高まりと需要も、特に新興地域において市場全体の拡大に貢献しています。
本調査レポートは、採血装置市場を製品（採血管、注射針・注射器、血液バッグ、採血システム／モニター、ランセット）、方法（手動採血および自動採血）、用途（診断用途および治療用途）、エンドユーザー（病院、ASC、介護施設、血液銀行、診断・病理学研究所、その他のエンドユーザー）、地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）別に分類しています。レポートは、採血装置市場の成長に影響を与える推進要因、制約要因、機会、課題などの主要要因に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、各社の事業概要、提供製品、主要戦略、買収、提携に関する洞察を提供しています。また、採血装置市場エコシステムにおける新興企業の競合分析も行っています。
本レポートは、採血装置市場全体およびサブセグメントの収益数値の近似値に関する情報を提供し、市場リーダー企業および新規参入企業にとって有益な情報となります。また、本レポートは、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供する上でも役立ちます。
本レポートは、以下の点について洞察を提供します。
- 採血装置市場の成長に影響を与える主要な推進要因（感染症および慢性疾患・生活習慣病の有病率上昇、病院および外科センター数の増加、事故および外傷症例の増加、リキッドバイオプシー検査の出現、献血および血液成分に対する需要と認知度の高まり）、制約要因（自動採血装置の高コスト）、機会（成分分析の需要増加、新興国における収益性の高い機会、採血手順および製品の進歩）、課題（複雑な保管・輸送、熟練した専門家の不足）の分析。
- 製品開発／イノベーション：採血装置市場における今後の技術、研究開発活動、新製品投入に関する詳細な洞察。
- 市場開発：収益性の高い市場に関する包括的な情報。本レポートでは、様々な地域における採血装置市場を分析しています。
- 市場の多様化：採血装置市場における新製品、未開拓地域、最近の動向、投資に関する包括的な情報。
- 競合評価: Fresenius Kabi AG (ドイツ)、Becton, Dickinson and Company (ND) (米国)、Terumo BCT, Inc. (日本)、Greiner Holding AG (オーストリア)、Cardinal Health (米国)、Haemonetics Corporation (米国)、Grifols, S.A. (スペイン)、Nipro Medical Corporation (日本)、SARSTEDT AG & Co. KG (ドイツ)、Macopharma (フランス)、ICU Medical, Inc. (米国)、Retractable Technologies, Inc. (米国) など、主要企業の市場シェア、成長戦略、製品提供の詳細な評価。
Report Description
The global blood collection devices market is projected to reach USD 13.02 billion by 2030 from USD 9.13 billion in 2025, at a CAGR of 7.4% during the forecast period. The blood collection devices market is driven by several key factors. The rising prevalence of infectious diseases, along with chronic and lifestyle-related conditions, has increased the need for frequent and reliable blood testing. At the same time, the growing number of hospitals and surgical centers worldwide is expanding healthcare infrastructure, creating greater demand for efficient blood collection solutions. The rise in accidents and trauma cases has further heightened the need for rapid and safe blood collection for emergency care and transfusions. Additionally, the emergence of liquid biopsy tests, which use blood samples for early cancer detection and monitoring, is driving the demand for advanced collection devices that ensure sample quality and accuracy. Growing awareness and the demand for blood donations and blood components are also contributing to the overall expansion of the market, particularly in emerging regions.
The automated blood collection segment is expected to grow at the highest rate during the forecast period.
The blood collection devices available in the market are based on two major methods: manual and automated blood collection methods. The automated blood collection segment is projected to register a higher CAGR during the forecast period. The growth of the automated blood collection segment can be attributed to the increasing demand for safer procedures and the availability of advanced blood collection products. However, the most widely used method in the blood collection devices market is manual blood collection. This segment accounted for the largest share of the market in 2024.
The hospitals, ASCs, and nursing homes segment accounted for the largest share of the blood collection devices market in 2024.
The hospitals, ASCs, and nursing homes segment accounted for the largest share of the blood collection devices market in 2024. The increasing incidence of infectious diseases and the rise in the number of trauma cases, as well as C-sections and organ transplants, have ensured the demand for blood collection equipment and devices in hospital facilities. This, along with expanded capabilities, is driving the growth of this market.
North America dominated the blood collection devices market in 2024.
North America, comprising the US and Canada, accounted for the largest share of the global blood collection devices market in 2024, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
- By Designation: C-level Executives (27%), Director-level Executives (18%), and Others (55%)
- By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
List of Companies Profiled in the Report
- Fresenius Kabi AG (Germany)
- Becton, Dickinson and Company (US)
- Terumo BCT, Inc. (Japan)
- Greiner Holding (Austria)
- Cardinal Health (US)
- Haemonetics Corporation (US)
- Grifols, S.A (Spain)
- Nipro Medical Corporation (Japan)
- SARSTEDT AG & Co. (Germany)
- Macopharma (France)
- ICU Medical, Inc. (US)
- Retractable Technologies, Inc. (US)
- Liuyang Sanli Medical Technology Development (China)
- F.L. Medical s.r.l. (Italy)
- AB Medical Co., Ltd. (South Korea)
- Aptaca SPA (Italy)
- Jiangsu Micsafe Medical Technology Co., Ltd. (China)
- Disera Tibbi Malzeme Lojistik Sanayi Ve Ticaret A.Ş (Turkey)
- Ajosha Bio Teknik Pvt. Ltd. (India)
- Preq Systems (India)
- CML Biotech (India)
- Lmb Technologie GmbH (Germany)
- Mitra Industries Private Limited (India)
- Neomedic Limited (UK)
Research Coverage
This research report categorizes the blood collection devices market by product (blood collection tubes, needles & syringes, blood bags, blood collection systems/monitors, and lancets), method (manual blood collection and automated blood collection), application (diagnostic applications and therapeutic applications), end user (hospitals, ASCs, and nursing homes; blood banks; diagnostic & pathology laboratories; and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the blood collection devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, key strategies, acquisitions, and partnerships. This report covers the competitive analysis of upcoming startups in the blood collection devices market ecosystem.
Key Benefits of Buying the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall blood collection devices market and subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (rising prevalence of infectious diseases and chronic & lifestyle diseases, increasing number of hospitals and surgical centers, rise in accidents and trauma cases, emergence of liquid biopsy tests, and growing demand for and awareness of blood donations and blood components), restraints (high cost of automated blood collection devices), opportunities (increasing demand for apheresis, lucrative opportunities in emerging economies, and advancements in blood collection procedures and products), and challenges (complex storage and shipping and lack of skilled professionals) influencing the growth of the blood collection devices market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood collection devices market.
- Market Development: Comprehensive information about lucrative markets; the report analyzes the blood collection devices market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood collection devices market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, such as Fresenius Kabi AG (Germany), Becton, Dickinson and Company (ND) (US), Terumo BCT, Inc. (Japan), Greiner Holding AG (Austria), Cardinal Health (US), Haemonetics Corporation (US), Grifols, S.A. (Spain), Nipro Medical Corporation (Japan), SARSTEDT AG & Co. KG (Germany), Macopharma (France), ICU Medical, Inc. (US), and Retractable Technologies, Inc. (US), among others.
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 MARKET SCOPE 29
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 29
1.3.2 INCLUSIONS AND EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED 30
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.1.1 SECONDARY RESEARCH 33
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY RESEARCH 34
2.1.2.1 Primary sources 34
2.1.2.2 Key objectives of primary research 35
2.1.2.3 Key data from primary sources 35
2.1.2.4 Key industry insights 36
2.2 MARKET SIZE ESTIMATION 37
2.2.1 BOTTOM-UP APPROACH 38
2.2.1.1 Approach 2: Presentations of companies and primary interviews 38
2.2.1.2 Growth forecast 39
2.2.2 TOP-DOWN APPROACH 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 41
2.4 MARKET SHARE ESTIMATION 41
2.5 RESEARCH ASSUMPTIONS 42
2.5.1 PARAMETRIC ASSUMPTIONS 42
2.5.2 GROWTH RATE ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42
2.7 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 47
4.1 BLOOD COLLECTION DEVICES MARKET OVERVIEW 47
4.2 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 48
4.3 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2025 VS. 2030 48
4.4 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 49
4.5 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2025 VS. 2030 49
4.6 BLOOD COLLECTION DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
5.2.1 DRIVERS 52
5.2.1.1 Rising prevalence of infectious diseases and chronic & lifestyle diseases 52
5.2.1.2 Increasing number of hospitals and surgical centers 54
5.2.1.3 Rise in accidents and trauma cases 55
5.2.1.4 Emergence of liquid biopsy tests 55
5.2.1.5 Growing demand for and awareness of blood donations and blood components 55
5.2.2 RESTRAINTS 57
5.2.2.1 Rising costs of automated blood collection devices 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Increasing demand for apheresis 57
5.2.3.2 Lucrative opportunities in emerging economies 57
5.2.3.3 Advancements in blood collection 58
5.2.4 CHALLENGES 58
5.2.4.1 Complex storage and shipping 58
5.2.4.2 Lack of skilled professionals 59
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59
5.4 PRICING ANALYSIS 60
5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 60
5.4.2 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER 60
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 61
5.5 VALUE CHAIN ANALYSIS 62
5.6 SUPPLY CHAIN ANALYSIS 63
5.7 ECOSYSTEM ANALYSIS 64
5.8 INVESTMENT AND FUNDING SCENARIO 65
5.9 TECHNOLOGY ANALYSIS 66
5.9.1 KEY TECHNOLOGIES 66
5.9.1.1 Core blood collection devices 66
5.9.2 COMPLEMENTARY TECHNOLOGIES 66
5.9.2.1 Sampling and collection kits 66
5.10 PATENT ANALYSIS 66
5.11 TRADE ANALYSIS 68
5.11.1 IMPORT DATA 69
5.11.2 EXPORT DATA 69
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 69
5.13 CASE STUDY ANALYSIS 70
5.13.1 CASE STUDY 1: REDUCING HOSPITAL-ONSET BACTEREMIA USING PIVO NEEDLELESS BLOOD COLLECTION 70
5.13.2 CASE STUDY 2: ADOPTION OF PIVO NEEDLE-FREE BLOOD COLLECTION DEVICE AT VIRGINIA MASON MEDICAL CENTER 70
5.13.3 CASE STUDY 3: AUTONOMOUS BLOOD COLLECTION ENHANCES EFFICIENCY AND PATIENT EXPERIENCE AT ST. ANTONIUS HOSPITAL 71
5.14 REGULATORY ANALYSIS 71
5.14.1 REGULATORY LANDSCAPE 71
5.14.1.1 North America 71
5.14.1.1.1 US 71
5.14.1.1.2 Canada 72
5.14.1.2 Europe 72
5.14.1.2.1 Germany 72
5.14.1.2.2 UK 73
5.14.1.2.3 France 73
5.14.1.2.4 Italy 73
5.14.1.2.5 Spain 74
5.14.1.3 Asia Pacific 74
5.14.1.3.1 China 74
5.14.1.3.2 Japan 74
5.14.1.3.3 India 75
5.14.1.4 Latin America 75
5.14.1.4.1 Brazil 75
5.14.1.4.2 Mexico 75
5.14.1.5 Middle East 75
5.14.1.6 Africa 76
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.15 PORTER’S FIVE FORCES ANALYSIS 78
5.15.1 BARGAINING POWER OF SUPPLIERS 79
5.15.2 BARGAINING POWER OF BUYERS 79
5.15.3 THREAT OF NEW ENTRANTS 79
5.15.4 THREAT OF SUBSTITUTES 79
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 80
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
5.16.2 BUYING CRITERIA 80
5.17 IMPACT OF GENERATIVE AI ON BLOOD COLLECTION DEVICES MARKET 81
5.17.1 INTRODUCTION 81
5.17.2 MARKET POTENTIAL FOR BLOOD COLLECTION DEVICES 81
5.17.3 AI USE CASES 82
5.17.4 KEY COMPANIES IMPLEMENTING AI 83
5.17.5 FUTURE OF GENERATIVE AI IN BLOOD COLLECTION DEVICES MARKET 83
5.18 IMPACT OF 2025 US TARIFFS ON BLOOD COLLECTION DEVICES MARKET 83
5.18.1 INTRODUCTION 83
5.18.2 KEY TARIFF RATES 84
5.18.3 PRICE IMPACT ANALYSIS 85
5.18.4 IMPACT ON COUNTRY/REGION 85
5.18.4.1 North America 85
5.18.4.2 Europe 85
5.18.4.3 Asia Pacific 85
5.18.5 IMPACT ON END-USE INDUSTRIES 85
5.18.5.1 Hospitals, ambulatory surgical centers, and nursing homes 86
5.18.5.2 Diagnostic & pathology labs 86
5.18.5.3 Blood banks 86
6 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
6.2 BLOOD COLLECTION TUBES 88
6.2.1 BLOOD COLLECTION TUBES MARKET, BY TYPE 88
6.2.1.1 Plasma/Whole-blood tubes 90
6.2.1.1.1 EDTA tubes 92
6.2.1.1.2 Heparin tubes 94
6.2.1.1.3 Coagulation tubes 96
6.2.1.1.4 Glucose tubes 98
6.2.1.1.5 ESR tubes 100
6.2.1.2 Serum tubes 102
6.2.1.2.1 Need for high-quality serum specimens to fuel market 102
6.2.2 BLOOD COLLECTION TUBES, BY SYSTEM TYPE 104
6.2.2.1 Vacuum tubes 105
6.2.2.1.1 Need to minimize blood exposure to promote growth 105
6.2.2.2 Non-vacuum tubes 106
6.2.2.2.1 Cost constraints to contribute to growth 106
6.3 NEEDLES & SYRINGES 109
6.3.1 RISING ADOPTION OF SAFETY BLOOD COLLECTION SETS TO BOLSTER GROWTH 109
6.4 BLOOD BAGS 111
6.4.1 INCREASING BLOOD DONATIONS WORLDWIDE TO AUGMENT GROWTH 111
6.5 BLOOD COLLECTION SYSTEMS/MONITORS 114
6.5.1 GROWING CONCERNS REGARDING BLOOD SAFETY AND BLOOD SHORTAGE TO PROPEL MARKET 114
6.6 LANCETS 116
6.6.1 HIGH CONVENIENCE AND MINIMAL PAIN TO CONTRIBUTE TO GROWTH 116
7 BLOOD COLLECTION DEVICES MARKET, BY METHOD 120
7.1 INTRODUCTION 121
7.2 MANUAL BLOOD COLLECTION 121
7.2.1 RISING INCLINATION TOWARD SELF-CARE AND INCREASING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE MARKET 121
7.3 AUTOMATED BLOOD COLLECTION 123
7.3.1 INCREASING DEMAND FOR SAFER COLLECTION PROCEDURES AND AVAILABILITY OF ADVANCED BLOOD-COLLECTING PRODUCTS TO AID GROWTH 123
8 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION 126
8.1 INTRODUCTION 127
8.2 DIAGNOSTIC APPLICATIONS 127
8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO SPUR GROWTH 127
8.3 THERAPEUTIC APPLICATIONS 130
8.3.1 RISING PREVALENCE OF HEMATOLOGICAL DISORDERS TO SUPPORT GROWTH 130
9 BLOOD COLLECTION DEVICES MARKET, BY END USER 133
9.1 INTRODUCTION 134
9.2 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES 134
9.2.1 INCREASING NUMBER OF SURGICAL PROCEDURES AND HOSPITALS TO FOSTER GROWTH 134
9.3 DIAGNOSTIC & PATHOLOGY LABORATORIES 136
9.3.1 RISING NUMBER OF TEST VOLUMES TO CONTRIBUTE TO GROWTH 136
9.4 BLOOD BANKS 138
9.4.1 INCREASING AWARENESS ABOUT BLOOD DONATION AND USE OF BLOOD FOR TREATING CLINICAL CONDITIONS TO BOOST MARKET 138
9.5 OTHER END USERS 140
10 BLOOD COLLECTION DEVICES MARKET, BY REGION 142
10.1 INTRODUCTION 143
10.2 NORTH AMERICA 143
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 147
10.2.2 US 148
10.2.2.1 High healthcare expenditure and increasing prevalence of cancer to expedite growth 148
10.2.3 CANADA 151
10.2.3.1 Growing volume of surgical procedures to support growth 151
10.3 EUROPE 154
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158
10.3.2 GERMANY 158
10.3.2.1 Increasing healthcare expenditure and new blood tests to aid growth 158
10.3.3 FRANCE 162
10.3.3.1 Growing number of new diagnostic tests and prevalence of cardiovascular diseases to drive market 162
10.3.4 UK 166
10.3.4.1 Increasing prevalence of lifestyle diseases and HIV to spur growth 166
10.3.5 ITALY 169
10.3.5.1 Rising blood donation to contribute to growth 169
10.3.6 SPAIN 172
10.3.6.1 Rise in organ transplants to aid growth 172
10.3.7 REST OF EUROPE 176
10.4 ASIA PACIFIC 180
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 184
10.4.2 JAPAN 184
10.4.2.1 Rapid increase in aging population to accelerate growth 184
10.4.3 CHINA 187
10.4.3.1 Growing demand for blood components to facilitate growth 187
10.4.4 INDIA 190
10.4.4.1 Rise in government initiatives for healthcare infrastructure to accelerate growth 190
10.4.5 AUSTRALIA 193
10.4.5.1 Growing emphasis on improving access to diagnostic and preventive healthcare to fuel market 193
10.4.6 REST OF ASIA PACIFIC 196
10.5 LATIN AMERICA 199
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 202
10.6 MIDDLE EAST & AFRICA 203
10.6.1 PREVALENCE OF INFECTIOUS DISEASES AND GROWING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 203
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 206
11 COMPETITIVE LANDSCAPE 207
11.1 OVERVIEW 207
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 207
11.2.1 OVERVIEW OF KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS 207
11.3 REVENUE ANALYSIS, 2022–2024 208
11.4 MARKET SHARE ANALYSIS, 2024 209
11.5 COMPANY VALUATION AND FINANCIAL METRICS 211
11.6 BRAND/PRODUCT COMPARISON 212
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 212
11.7.1 STARS 212
11.7.2 EMERGING LEADERS 213
11.7.3 PERVASIVE PLAYERS 213
11.7.4 PARTICIPANTS 213
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 214
11.7.5.1 Company footprint 214
11.7.5.2 Region footprint 214
11.7.5.3 Product footprint 215
11.7.5.4 Application footprint 215
11.7.5.5 Method footprint 216
11.8 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 216
11.8.1 PROGRESSIVE COMPANIES 216
11.8.2 RESPONSIVE COMPANIES 216
11.8.3 DYNAMIC COMPANIES 217
11.8.4 STARTING BLOCKS 217
11.8.5 COMPETITIVE BENCHMARKING 218
11.8.5.1 Detailed list of key startups/SMEs 218
11.8.5.2 Competitive benchmarking of key startups/SMEs 218
11.9 COMPETITIVE SCENARIO 219
11.9.1 PRODUCT LAUNCHES AND APPROVALS 219
11.9.2 DEALS 220
11.9.3 EXPANSIONS 220
12 COMPANY PROFILES 221
12.1 KEY PLAYERS 221
12.1.1 BECTON, DICKINSON AND COMPANY (BD) 221
12.1.1.1 Business overview 221
12.1.1.2 Products offered 222
12.1.1.3 Recent developments 224
12.1.1.3.1 Product launches and approvals 224
12.1.1.3.2 Expansions 224
12.1.1.3.3 Deals 224
12.1.1.4 MnM view 225
12.1.1.4.1 Key strengths 225
12.1.1.4.2 Strategic choices 225
12.1.1.4.3 Weaknesses and competitive threats 225
12.1.2 TERUMO BCT, INC. 226
12.1.2.1 Business overview 226
12.1.2.2 Products offered 228
12.1.2.3 Recent developments 229
12.1.2.3.1 Deals 229
12.1.2.4 MnM view 229
12.1.2.4.1 Key strengths 229
12.1.2.4.2 Strategic choices 229
12.1.2.4.3 Weaknesses and competitive threats 229
12.1.3 FRESENIUS KABI AG 230
12.1.3.1 Business overview 230
12.1.3.2 Products offered 232
12.1.3.3 Recent developments 232
12.1.3.3.1 Product launches and approvals 232
12.1.3.4 MnM view 232
12.1.3.4.1 Key strengths 232
12.1.3.4.2 Strategic choices 232
12.1.3.4.3 Weaknesses and competitive threats 233
12.1.4 GRIFOLS, S.A. 234
12.1.4.1 Business overview 234
12.1.4.2 Products offered 235
12.1.5 NIPRO CORPORATION 236
12.1.5.1 Business overview 236
12.1.5.2 Products offered 237
12.1.6 SARSTEDT AG & CO. KG 238
12.1.6.1 Business overview 238
12.1.6.2 Products offered 238
12.1.7 MACOPHARMA 239
12.1.7.1 Business overview 239
12.1.7.2 Products offered 239
12.1.8 HAEMONETICS CORPORATION 240
12.1.8.1 Business overview 240
12.1.8.2 Products offered 241
12.1.8.3 Recent developments 242
12.1.8.3.1 Deals 242
12.1.8.3.2 Product launches and approvals 242
12.1.8.3.3 Expansions 242
12.1.9 ICU MEDICAL, INC. 243
12.1.9.1 Business overview 243
12.1.9.2 Products offered 244
12.1.10 CARDINAL HEALTH 245
12.1.10.1 Business overview 245
12.1.10.2 Products offered 246
12.1.11 RETRACTABLE TECHNOLOGIES, INC. 248
12.1.11.1 Business overview 248
12.1.11.2 Products offered 249
12.1.12 GREINER HOLDING AG 250
12.1.12.1 Business overview 250
12.1.12.2 Products offered 251
12.2 OTHER PLAYERS 253
12.2.1 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. 253
12.2.2 FL MEDICAL S.R.L. 254
12.2.3 AB MEDICAL CO., LTD. 255
12.2.4 APTACA SPA 256
12.2.5 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD. 257
12.2.6 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.Ş 257
12.2.7 AJOSHA BIO TEKNIK PVT. LTD. 258
12.2.8 PREQ SYSTEMS 259
12.2.9 CML BIOTECH LTD 259
12.2.10 LMB TECHNOLOGIE GMBH 260
12.2.11 MITRA INDUSTRIES PRIVATE LIMITED 260
12.2.12 NEOMEDIC LIMITED 261
12.2.13 MHC MEDICAL PRODUCTS, LLC 261
13 APPENDIX 262
13.1 DISCUSSION GUIDE 262
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266
13.3 CUSTOMIZATION OPTIONS 268
13.4 RELATED REPORTS 268
13.5 AUTHOR DETAILS 269
LIST OF TABLES
TABLE 1 BLOOD COLLECTION DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES 35
TABLE 2 BLOOD COLLECTION DEVICES MARKET: RISK ANALYSIS 43
TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD COLLECTION TUBES AND LANCETS, 2023–2025 (USD) 60
TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY KEY PLAYER, 2023–2025 (USD) 61
TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD COLLECTION DEVICES, BY REGION, 2023–2025 (USD) 61
TABLE 6 BLOOD COLLECTION DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64
TABLE 7 BLOOD COLLECTION DEVICES MARKET: LIST OF MAJOR PATENTS, 2023–2025 68
TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019–2023 (USD MILLION) 69
TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 69
TABLE 10 BLOOD COLLECTION DEVICES MARKET: KEY CONFERENCES AND EVENTS,
2025–2026 69
TABLE 11 EUROPE: CLASSIFICATION OF DEVICES 72
TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 74
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 18 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 79
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 80
TABLE 20 KEY BUYING CRITERIA, BY END USER 81
TABLE 21 RECIPROCAL TARIFF RATES ADJUSTED BY US 84
TABLE 22 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 88
TABLE 23 BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 88
TABLE 24 BLOOD COLLECTION TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 89
TABLE 25 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 89
TABLE 26 EUROPE: BLOOD COLLECTION TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 89
TABLE 27 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 90
TABLE 28 PLASMA/WHOLE-BLOOD TUBES AVAILABLE IN MARKET 90
TABLE 29 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 91
TABLE 30 BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY REGION, 2023–2030 (USD MILLION) 91
TABLE 31 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 32 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 33 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 92
TABLE 34 EDTA TUBES AVAILABLE IN MARKET 93
TABLE 35 BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY REGION,
2023–2030 (USD MILLION) 93
TABLE 36 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 37 EUROPE: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 38 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR EDTA TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 94
TABLE 39 HEPARIN TUBES AVAILABLE IN MARKET 95
TABLE 40 BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY REGION,
2023–2030 (USD MILLION) 95
TABLE 41 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 95
TABLE 42 EUROPE: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 43 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR HEPARIN TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 96
TABLE 44 COAGULATION TUBES AVAILABLE IN MARKET 96
TABLE 45 BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY REGION, 2023–2030 (USD MILLION) 97
TABLE 46 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 97
TABLE 47 EUROPE: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 48 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR COAGULATION TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 98
TABLE 49 GLUCOSE TUBES AVAILABLE IN MARKET 99
TABLE 50 BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 51 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 99
TABLE 52 EUROPE: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 53 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR GLUCOSE TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 54 ESR TUBES AVAILABLE IN MARKET 101
TABLE 55 BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY REGION,
2023–2030 (USD MILLION) 101
TABLE 56 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 57 EUROPE: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 58 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR ESR TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 102
TABLE 59 SERUM TUBES AVAILABLE IN MARKET 103
TABLE 60 BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY REGION,
2023–2030 (USD MILLION) 103
TABLE 61 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 62 EUROPE: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 63 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR SERUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 64 BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 104
TABLE 65 VACUUM TUBES AVAILABLE IN MARKET 105
TABLE 66 BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 67 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 105
TABLE 68 EUROPE: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 69 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR VACUUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 70 NON-VACUUM TUBES AVAILABLE IN MARKET 107
TABLE 71 BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY REGION, 2023–2030 (USD MILLION) 107
TABLE 72 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 73 EUROPE: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 74 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR NON-VACUUM TUBES,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 75 NEEDLES & SYRINGES AVAILABLE IN MARKET 109
TABLE 76 BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY REGION, 2023–2030 (USD MILLION) 110
TABLE 77 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 78 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES,
BY COUNTRY, 2023–2030 (USD MILLION) 110
TABLE 79 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR NEEDLES & SYRINGES, BY COUNTRY, 2023–2030 (USD MILLION) 111
TABLE 80 BLOOD BAGS AVAILABLE IN MARKET 111
TABLE 81 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 82 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS,
BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 83 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS, BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 84 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BAGS,
BY COUNTRY, 2023–2030 (USD MILLION) 113
TABLE 85 BLOOD COLLECTION SYSTEMS/MONITORS AVAILABLE IN MARKET 114
TABLE 86 BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY REGION, 2023–2030 (USD MILLION) 115
TABLE 87 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 88 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 89 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD COLLECTION SYSTEMS/MONITORS, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 90 LANCETS AVAILABLE IN MARKET 117
TABLE 91 BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY REGION,
2023–2030 (USD MILLION) 117
TABLE 92 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR LANCETS,
BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 93 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 94 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR LANCETS, BY COUNTRY, 2023–2030 (USD MILLION) 118
TABLE 95 GLOBAL NUMBER OF LANCETS MANUFACTURED, 2023–2030 (UNITS) 119
TABLE 96 BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 121
TABLE 97 BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION,
BY REGION, 2023–2030 (USD MILLION) 122
TABLE 98 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 99 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 100 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 101 BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION,
BY REGION, 2023–2030 (USD MILLION) 124
TABLE 102 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 103 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 104 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 105 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 127
TABLE 106 REGIONAL HIV DATA, 2024 127
TABLE 107 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 129
TABLE 108 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 109 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 110 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 111 BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2023–2030 (USD MILLION) 131
TABLE 112 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 113 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 131
TABLE 114 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 115 BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 134
TABLE 116 BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 117 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 118 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 119 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 120 BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 137
TABLE 121 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 122 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 123 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 124 BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS, BY REGION,
2023–2030 (USD MILLION) 139
TABLE 125 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 126 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 127 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR BLOOD BANKS,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 128 BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 140
TABLE 129 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 130 EUROPE: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 131 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 132 BLOOD COLLECTION DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 133 NORTH AMERICA: MACROECONOMIC INDICATORS 144
TABLE 134 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 145
TABLE 135 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 145
TABLE 136 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 145
TABLE 137 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 138 NORTH AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 146
TABLE 139 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 146
TABLE 140 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147
TABLE 141 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 147
TABLE 142 US: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 149
TABLE 143 US: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 144 US: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 145 US: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 150
TABLE 146 US: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 151
TABLE 147 US: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 151
TABLE 148 US: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 151
TABLE 149 SURGICAL PROCEDURES PERFORMED IN CANADA, 2024 152
TABLE 150 CANADA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 152
TABLE 151 CANADA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 152 CANADA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 153 CANADA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 153
TABLE 154 CANADA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 154
TABLE 155 CANADA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 154
TABLE 156 CANADA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 154
TABLE 157 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 155
TABLE 158 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 156
TABLE 159 EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 160 EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 161 EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 157
TABLE 162 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 157
TABLE 163 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 157
TABLE 164 EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 158
TABLE 165 SURGICAL PROCEDURES PERFORMED IN GERMANY, 2024 159
TABLE 166 GERMANY: KEY MACROECONOMIC INDICATORS 159
TABLE 167 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 160
TABLE 168 GERMANY: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 169 GERMANY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 160
TABLE 170 GERMANY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 161
TABLE 171 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 161
TABLE 172 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 161
TABLE 173 GERMANY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 162
TABLE 174 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2024 163
TABLE 175 FRANCE: KEY MACROECONOMIC INDICATORS 163
TABLE 176 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 163
TABLE 177 FRANCE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 164
TABLE 178 FRANCE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 179 FRANCE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 164
TABLE 180 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 165
TABLE 181 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 165
TABLE 182 FRANCE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 165
TABLE 183 SURGICAL PROCEDURES PERFORMED IN UK, 2024 166
TABLE 184 UK: KEY MACROECONOMIC INDICATORS 167
TABLE 185 UK: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 167
TABLE 186 UK: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 187 UK: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 188 UK: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 168
TABLE 189 UK: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 168
TABLE 190 UK: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 169
TABLE 191 UK: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 192 SURGICAL PROCEDURES PERFORMED IN ITALY, 2024 170
TABLE 193 ITALY: KEY MACROECONOMIC INDICATORS 170
TABLE 194 ITALY: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 170
TABLE 195 ITALY: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 196 ITALY: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 171
TABLE 197 ITALY: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 171
TABLE 198 ITALY: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 172
TABLE 199 ITALY: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 172
TABLE 200 ITALY: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 172
TABLE 201 SURGICAL PROCEDURES PERFORMED IN SPAIN, 2024 173
TABLE 202 SPAIN: KEY MACROECONOMIC INDICATORS 173
TABLE 203 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 174
TABLE 204 SPAIN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 205 SPAIN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 174
TABLE 206 SPAIN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 175
TABLE 207 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 175
TABLE 208 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 175
TABLE 209 SPAIN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 176
TABLE 210 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY,
2020 VS. 2024 (% OF GDP) 176
TABLE 211 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050 177
TABLE 212 SURGICAL PROCEDURES PERFORMED IN SWITZERLAND, 2024 177
TABLE 213 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 178
TABLE 214 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 215 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 216 REST OF EUROPE: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 179
TABLE 217 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 179
TABLE 218 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179
TABLE 219 REST OF EUROPE: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 180
TABLE 220 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 181
TABLE 221 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 182
TABLE 222 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 182
TABLE 223 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 182
TABLE 224 ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 183
TABLE 225 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 183
TABLE 226 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 183
TABLE 227 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 184
TABLE 228 JAPAN: KEY MACROECONOMIC INDICATORS 185
TABLE 229 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 185
TABLE 230 JAPAN: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185
TABLE 231 JAPAN: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 232 JAPAN: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 186
TABLE 233 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 186
TABLE 234 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 187
TABLE 235 JAPAN: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 187
TABLE 236 CHINA: KEY MACROECONOMIC INDICATORS 188
TABLE 237 CHINA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 188
TABLE 238 CHINA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188
TABLE 239 CHINA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 240 CHINA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 189
TABLE 241 CHINA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 189
TABLE 242 CHINA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 190
TABLE 243 CHINA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 190
TABLE 244 INDIA: KEY MACROECONOMIC INDICATORS 191
TABLE 245 INDIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 191
TABLE 246 INDIA: BLOOD COLLECTION TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 247 INDIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 248 INDIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 192
TABLE 249 INDIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 193
TABLE 250 INDIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 193
TABLE 251 INDIA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 193
TABLE 252 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 194
TABLE 253 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 254 AUSTRALIA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 255 AUSTRALIA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 195
TABLE 256 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 195
TABLE 257 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 196
TABLE 258 AUSTRALIA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 196
TABLE 259 SURGICAL PROCEDURES IN SOUTH KOREA, 2024 197
TABLE 260 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 197
TABLE 261 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 198
TABLE 262 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 263 REST OF ASIA PACIFIC: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 198
TABLE 264 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 199
TABLE 265 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199
TABLE 266 REST OF ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199
TABLE 267 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 200
TABLE 268 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 200
TABLE 269 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 200
TABLE 270 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 271 LATIN AMERICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE,
2023–2030 (USD MILLION) 201
TABLE 272 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2023–2030 (USD MILLION) 201
TABLE 273 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 202
TABLE 274 LATIN AMERICA: BLOOD COLLECTION DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 202
TABLE 275 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 204
TABLE 276 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204
TABLE 277 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY TYPE,
2023–2030 (USD MILLION) 204
TABLE 278 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET FOR PLASMA/WHOLE-BLOOD COLLECTION TUBES, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 279 MIDDLE EAST & AFRICA: BLOOD COLLECTION TUBES MARKET, BY SYSTEM TYPE, 2023–2030 (USD MILLION) 205
TABLE 280 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY METHOD, 2023–2030 (USD MILLION) 205
TABLE 281 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 206
TABLE 282 MIDDLE EAST & AFRICA: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 206
TABLE 283 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, JANUARY 2022−JUNE 2025 207
TABLE 284 BLOOD COLLECTION DEVICES MARKET: DEGREE OF COMPETITION 210
TABLE 285 BLOOD COLLECTION DEVICES MARKET: REGION FOOTPRINT 214
TABLE 286 BLOOD COLLECTION DEVICES MARKET: PRODUCT FOOTPRINT 215
TABLE 287 BLOOD COLLECTION DEVICES MARKET: APPLICATION FOOTPRINT 215
TABLE 288 BLOOD COLLECTION DEVICES MARKET: METHOD FOOTPRINT 216
TABLE 289 BLOOD COLLECTION DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 218
TABLE 290 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND METHOD 218
TABLE 291 BLOOD COLLECTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 219
TABLE 292 BLOOD COLLECTION DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 219
TABLE 293 BLOOD COLLECTION DEVICES MARKET: DEALS, JANUARY 2022–JULY 2025 220
TABLE 294 BLOOD COLLECTION DEVICES MARKET: EXPANSIONS, JANUARY 2022–JULY 2025 220
TABLE 295 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 221
TABLE 296 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 222
TABLE 297 BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 224
TABLE 298 BECTON, DICKINSON AND COMPANY (BD): EXPANSIONS,
JANUARY 2022–JULY 2025 224
TABLE 299 BECTON, DICKINSON AND COMPANY (BD): DEALS, JANUARY 2022–JULY 2025 224
TABLE 300 TERUMO BCT, INC.: COMPANY OVERVIEW 226
TABLE 301 EXCHANGE RATES USED FOR CONVERSION OF YEN TO USD, 2022–2024 227
TABLE 302 TERUMO BCT, INC.: PRODUCTS OFFERED 228
TABLE 303 TERUMO BCT, INC.: DEALS, JANUARY 2022–JULY 2025 229
TABLE 304 FRESENIUS KABI AG: COMPANY OVERVIEW 230
TABLE 305 EXCHANGE RATES USED FOR CONVERSION OF EURO TO USD, 2022–2024 231
TABLE 306 FRESENIUS KABI AG: PRODUCTS OFFERED 232
TABLE 307 FRESENIUS KABI AG: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JULY 2025 232
TABLE 308 GRIFOLS, S.A.: COMPANY OVERVIEW 234
TABLE 309 GRIFOLS, S.A.: PRODUCTS OFFERED 235
TABLE 310 NIPRO CORPORATION: BUSINESS OVERVIEW 236
TABLE 311 NIPRO CORPORATION: PRODUCTS OFFERED 237
TABLE 312 SARSTEDT AG & CO. KG: COMPANY OVERVIEW 238
TABLE 313 SARSTEDT AG & CO. KG: PRODUCTS OFFERED 238
TABLE 314 MACOPHARMA: COMPANY OVERVIEW 239
TABLE 315 MACOPHARMA: PRODUCTS OFFERED 239
TABLE 316 HAEMONETICS CORPORATION: COMPANY OVERVIEW 240
TABLE 317 HAEMONETICS CORPORATION: PRODUCTS OFFERED 241
TABLE 318 HAEMONETICS CORPORATION: DEALS, JANUARY 2022–JULY 2025 242
TABLE 319 HAEMONETICS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–JULY 2025 242
TABLE 320 HAEMONETICS CORPORATION: EXPANSIONS, JANUARY 2022–JULY 2025 242
TABLE 321 ICU MEDICAL, INC.: COMPANY OVERVIEW 243
TABLE 322 ICU MEDICAL, INC.: PRODUCTS OFFERED 244
TABLE 323 CARDINAL HEALTH: COMPANY OVERVIEW 245
TABLE 324 CARDINAL HEALTH: PRODUCTS OFFERED 246
TABLE 325 RETRACTABLE TECHNOLOGIES, INC.: COMPANY OVERVIEW 248
TABLE 326 RETRACTABLE TECHNOLOGIES, INC.: PRODUCTS OFFERED 249
TABLE 327 GREINER HOLDING AG: COMPANY OVERVIEW 250
TABLE 328 GREINER HOLDING AG: PRODUCTS OFFERED 251
TABLE 329 LIUYANG SANLI MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.:
COMPANY OVERVIEW 253
TABLE 330 FL MEDICAL S.R.L.: COMPANY OVERVIEW 254
TABLE 331 AB MEDICAL CO., LTD.: COMPANY OVERVIEW 255
TABLE 332 APTACA SPA: COMPANY OVERVIEW 256
TABLE 333 JIANGSU MICSAFE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 257
TABLE 334 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.Ş: COMPANY OVERVIEW 257
TABLE 335 AJOSHA BIO TEKNIK PVT. LTD.: COMPANY OVERVIEW 258
TABLE 336 PREQ SYSTEMS: COMPANY OVERVIEW 259
TABLE 337 CML BIOTECH LTD: COMPANY OVERVIEW 259
TABLE 338 LMB TECHNOLOGIE GMBH: COMPANY OVERVIEW 260
TABLE 339 MITRA INDUSTRIES PRIVATE LIMITED: COMPANY OVERVIEW 260
TABLE 340 NEOMEDIC LIMITED: COMPANY OVERVIEW 261
TABLE 341 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW 261
LIST OF FIGURES
FIGURE 1 BLOOD COLLECTION DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE 29
FIGURE 2 RESEARCH DESIGN 32
FIGURE 3 BLOOD COLLECTION DEVICES MARKET: KEY PRIMARY SOURCES 34
FIGURE 4 BLOOD COLLECTION DEVICES MARKET: KEY INSIGHTS FROM PRIMARIES 36
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 37
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 37
FIGURE 7 BLOOD COLLECTION DEVICES MARKET: COMPANY REVENUE ESTIMATION APPROACH 38
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
FIGURE 9 TOP-DOWN APPROACH 40
FIGURE 10 DATA TRIANGULATION METHODOLOGY 41
FIGURE 11 BLOOD COLLECTION DEVICES MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 44
FIGURE 12 BLOOD COLLECTION DEVICES MARKET, BY METHOD,
2025 VS. 2030 (USD MILLION) 45
FIGURE 13 BLOOD COLLECTION DEVICES MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 45
FIGURE 14 BLOOD COLLECTION DEVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 46
FIGURE 15 BLOOD COLLECTION DEVICES MARKET, BY REGION,
2025 VS. 2030 (USD MILLION) 46
FIGURE 16 INCREASING DISEASE INCIDENCE AND DEMAND FOR BLOOD COMPONENTS TO DRIVE MARKET 47
FIGURE 17 BLOOD COLLECTION TUBES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 48
FIGURE 18 MANUAL BLOOD COLLECTION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 48
FIGURE 19 DIAGNOSTIC APPLICATIONS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD 49
FIGURE 20 HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030 49
FIGURE 21 NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 50
FIGURE 22 BLOOD COLLECTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 23 INCREASING INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION) 53
FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 62
FIGURE 26 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY FOR PROMINENT COMPANIES 63
FIGURE 27 BLOOD COLLECTION DEVICES MARKET: ECOSYSTEM ANALYSIS 65
FIGURE 28 BLOOD COLLECTION DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2020−2023 65
FIGURE 29 BLOOD COLLECTION DEVICES MARKET: PATENT ANALYSIS,
JANUARY 2014–DECEMBER 2024 67
FIGURE 30 BLOOD COLLECTION DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 78
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 80
FIGURE 32 KEY BUYING CRITERIA, BY END USER 80
FIGURE 33 AI USE CASES 82
FIGURE 34 NORTH AMERICA: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 144
FIGURE 35 ASIA PACIFIC: BLOOD COLLECTION DEVICES MARKET SNAPSHOT 181
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD COLLECTION DEVICES MARKET, 2022–2024 209
FIGURE 37 BLOOD COLLECTION DEVICES MARKET SHARE ANALYSIS, 2024 210
FIGURE 38 EV/EBITDA OF KEY VENDORS 211
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 211
FIGURE 40 BLOOD COLLECTION DEVICES MARKET: BRAND/PRODUCT COMPARISON 212
FIGURE 41 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 213
FIGURE 42 BLOOD COLLECTION DEVICES MARKET: COMPANY FOOTPRINT 214
FIGURE 43 BLOOD COLLECTION DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 217
FIGURE 44 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 222
FIGURE 45 TERUMO BCT, INC.: COMPANY SNAPSHOT (2023) 227
FIGURE 46 FRESENIUS KABI AG: COMPANY SNAPSHOT (2024) 231
FIGURE 47 GRIFOLS, S.A.: COMPANY SNAPSHOT (2024) 235
FIGURE 48 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 237
FIGURE 49 HAEMONETICS CORPORATION: COMPANY SNAPSHOT (2024) 241
FIGURE 50 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 244
FIGURE 51 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 246
FIGURE 52 RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 249
FIGURE 53 GREINER HOLDING AG: COMPANY SNAPSHOT (2024) 251
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11